Effect of the Increase of daily steps in Urinary symptoms and Cardiac function in men aged 50 to 59 years
Not Applicable
- Conditions
- Men with lower urinary tract symptomsC12.294.565N00-N99
- Registration Number
- RBR-4vynk5
- Lead Sponsor
- Hospital Universitàrio da Faculdade de Medicina da Universidade Federal de Juiz de Fora
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
men, aged 50 to 59 years, complain of lower urinary tract symptoms with a result greater than or equal to eight in the application of the International Prostate Symptom Score instrument
Exclusion Criteria
Tobacco use, conditions that make physical exercise unfeasible, chronic or prostatic diseases, previous history of bladder or prostatic surgery, neurological dysfunction of the bladder, bladder neck or urethral stenosis, as well as lithiasis, carcinoma or bladder polyposis, recurrent UTI, concomitant use or in the month prior to inclusion of any drug or condition affecting urinary function, cardiological and neurological diseases and use of any drug or substance that had action in the autonomic nervous system.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endpoint found:<br>After an intervention period of 12 weeks, regarding the primary endpoint, to reach the goal of 10,000 steps daily, the intervention group that made use of the pedometer obtained better results. The number of steps per day in the intervention group was 9753 ± 1549 compared to 6212 ± 1152, p < 0,001;Expected endpoint:<br>The primary endpoint with respect to the effect of the pedometer use was the increase of number of steps per day after 12 weeks of intervention. Based on an expected increase of 1250 steps per day with a standard deviation of 1400 steps and adopting a 95% confidence interval, alpha error of 0.05, study power of 80% and a two-tailed hypothesis, a total of 38 men were required.
- Secondary Outcome Measures
Name Time Method Expected endpoint:<br>Improvement of lower urinary tract symptoms through decrease in international prostatic symptoms (IPSS) score<br>;Endpoint found:<br>Regarding the IPSS score, the intervention group achieved lower scores than the control groups (6.95 ± 2.85 vs 10.16 ± 3.23, p<0,001)<br>;Expected endpoint:<br>Improvements of cardiorespiratory fitness though indirect maximum oxygen cunsumption measurement;Endpint found:<br>In the analysis of the cardiorespiratory fitness evaluated through the indirect measure of maximum oxygen consumption, the intervention group performed better than the control group (34.84 ± 3.25 vs 32.58 ± 6.89, p=0,011). ;Expected endpoint:<br>Improvement of anthropometric measures though abdomen circumference, body mass index and hip and hip waist ratio;Endpoint found:<br>there was no difference in anthropometric values between the groups;Expected endpoint:<br>Improvement of flexibility measures ;Endpoint found:<br>there was no difference in flexibility values between the groups